Skip to content

13G/A filed by BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 8,650,158 GHRS shares, 12.6% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:14:27 UTC.

Accession
0000921895-26-003180
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
8,650,158
Percent of class
12.6%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group BVF INC/IL.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
BIOTECHNOLOGY VALUE FUND L PPN04,507,69004,507,6904,507,6906.6%
BVF I GP LLCOO04,507,69004,507,6904,507,6906.6%
BIOTECHNOLOGY VALUE FUND II LPPN03,531,79003,531,7903,531,7905.1%
BVF II GP LLCOO03,531,79003,531,7903,531,7905.1%
Biotechnology Value Trading Fund OS LPPN0610,6780610,678610,6780.9%
BVF Partners OS Ltd.CO0610,6780610,678610,6780.9%
BVF GP HOLDINGS LLCOO08,039,48008,039,4808,039,48011.7%
BVF PARTNERS L P/ILIA,PN08,650,15808,650,1588,650,15812.6%
BVF INC/ILCO08,650,15808,650,1588,650,15812.6%
LAMPERT MARK NIN08,650,15808,650,1588,650,15812.6%